ImmunoGen Alpha and Beta Analysis
| IMGNDelisted Stock | USD 18.20 0.81 4.26% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as ImmunoGen. It also helps investors analyze the systematic and unsystematic risks associated with investing in ImmunoGen over a specified time horizon. Remember, high ImmunoGen's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to ImmunoGen's market risk premium analysis include:
Beta 2.1 | Alpha 2.74 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
ImmunoGen |
ImmunoGen Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. ImmunoGen market risk premium is the additional return an investor will receive from holding ImmunoGen long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ImmunoGen. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate ImmunoGen's performance over market.| α | 2.74 | β | 2.10 |
ImmunoGen Fundamentals Vs Peers
Comparing ImmunoGen's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ImmunoGen's direct or indirect competition across all of the common fundamentals between ImmunoGen and the related equities. This way, we can detect undervalued stocks with similar characteristics as ImmunoGen or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ImmunoGen's fundamental indicators could also be used in its relative valuation, which is a method of valuing ImmunoGen by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare ImmunoGen to competition |
| Fundamentals | ImmunoGen | Peer Average |
| Return On Equity | -0.2 | -0.31 |
| Return On Asset | -0.0849 | -0.14 |
| Profit Margin | (0.26) % | (1.27) % |
| Operating Margin | 0.23 % | (5.51) % |
| Current Valuation | 8.2 B | 16.62 B |
| Shares Outstanding | 279.35 M | 571.82 M |
| Shares Owned By Insiders | 0.32 % | 10.09 % |
ImmunoGen Opportunities
ImmunoGen Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About ImmunoGen Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including ImmunoGen or other delisted stocks. Alpha measures the amount that position in ImmunoGen has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
ImmunoGen Upcoming Company Events
As portrayed in its financial statements, the presentation of ImmunoGen's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ImmunoGen's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of ImmunoGen's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of ImmunoGen. Please utilize our Beneish M Score to check the likelihood of ImmunoGen's management manipulating its earnings.
| 6th of March 2024 Upcoming Quarterly Report | View | |
| 26th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with ImmunoGen
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in ImmunoGen Stock
If you are still planning to invest in ImmunoGen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ImmunoGen's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |